|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
383,180,000 |
Market
Cap: |
1.49(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.255 - $9.15 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ImmunityBio is a clinical-stage biotechnology company developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. Co.'s platforms include: antibody cytokine fusion proteins, which include Anktiva, a class of biopharmaceuticals that enhance the therapeutic potential of cytokines, and promote lymphocyte infiltration at a site of disease, improving immune response; and DNA, RNA, and recombinant protein vaccine technologies, which are for infectious diseases to target viruses, including SARS-CoV-2, and for oncology to deliver common tumor-associated antigens, and neoepitopes (expressed only by cancer cells).
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
103,915 |
Total Buy Value |
$0 |
$0 |
$0 |
$289,093 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Tajak Richard J. |
Chief Financial Officer |
|
2016-12-23 |
4 |
D |
$6.15 |
$10,560 |
D/D |
(1,717) |
9,858 |
|
- |
|
Tajak Richard J. |
Chief Financial Officer |
|
2016-12-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
11,575 |
|
- |
|
Thomas John C |
Director |
|
2016-11-25 |
4 |
S |
$7.50 |
$46,260 |
D/D |
(6,168) |
309,621 |
|
- |
|
Thomas John C |
Director |
|
2016-11-23 |
4/A |
S |
$7.50 |
$57,893 |
D/D |
(7,719) |
315,070 |
|
- |
|
Thomas John C |
Director |
|
2016-11-23 |
4 |
S |
$7.50 |
$52,500 |
D/D |
(7,000) |
315,789 |
|
- |
|
Thomas John C |
Director |
|
2016-11-22 |
4 |
S |
$7.50 |
$97,500 |
D/D |
(13,000) |
322,789 |
|
- |
|
Gorlin Steve |
Director |
|
2016-10-07 |
5 |
GA |
$0.00 |
$0 |
I/I |
300,000 |
521,720 |
|
- |
|
Gorlin Steve |
Director |
|
2016-10-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
429,725 |
|
- |
|
Tajak Richard J. |
Chief Financial Officer |
|
2016-09-23 |
4 |
D |
$7.91 |
$13,581 |
D/D |
(1,717) |
6,575 |
|
- |
|
Tajak Richard J. |
Chief Financial Officer |
|
2016-09-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
8,292 |
|
- |
|
Simon Barry J. |
President and COO |
|
2016-09-08 |
4 |
S |
$7.40 |
$222,000 |
D/D |
(30,000) |
3,334,906 |
|
- |
|
Simon Barry J. |
President and COO |
|
2016-09-07 |
4 |
S |
$8.84 |
$17,671 |
I/I |
(2,000) |
21,143 |
|
- |
|
Thomas John C |
Director |
|
2016-08-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
307,402 |
|
- |
|
Potts John T Jr |
Director |
|
2016-08-03 |
5 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
135,500 |
|
- |
|
Potts John T Jr |
Director |
|
2016-08-02 |
5 |
OE |
$0.22 |
$29,282 |
D/D |
135,500 |
235,500 |
|
- |
|
Simon Barry J. |
President and COO |
|
2016-07-27 |
4 |
D |
$6.89 |
$546,529 |
D/D |
(79,322) |
3,364,906 |
|
- |
|
Simon Barry J. |
President and COO |
|
2016-07-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
185,150 |
3,444,228 |
|
- |
|
Chan Soon-Shiong Family Foundation |
Chairman and CEO |
|
2016-07-07 |
4 |
B |
$0.00 |
$0 |
I/I |
5,618,326 |
5,618,326 |
1.42 |
- |
|
Tajak Richard J. |
Chief Financial Officer |
|
2016-06-23 |
4 |
D |
$6.73 |
$11,495 |
D/D |
(1,708) |
3,292 |
|
- |
|
Tajak Richard J. |
Chief Financial Officer |
|
2016-06-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
Thomas John C |
Director |
|
2016-05-26 |
4 |
OE |
$0.22 |
$60,016 |
D/D |
277,725 |
335,789 |
|
- |
|
Gorlin Steve |
Director |
|
2016-05-23 |
4 |
OE |
$0.22 |
$70,019 |
D/D |
324,012 |
729,725 |
|
- |
|
Blaszyk Michael D |
Director |
|
2016-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Kusserow Richard |
Director |
|
2016-03-17 |
4 |
OE |
$0.22 |
$3,334 |
D/D |
15,429 |
370,300 |
|
- |
|
Thomas John C |
Director |
|
2016-03-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,000 |
58,064 |
|
- |
|
195 Records found
|
|
Page 7 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|